Clinical Trials Directory

Trials / Sponsors / Minghui Pharmaceutical (Hangzhou) Ltd

Minghui Pharmaceutical (Hangzhou) Ltd

Industry · 16 registered clinical trials — 11 currently recruiting.

StatusTrialPhaseStarted
RecruitingMHB018A Treatment in Patients With Chronic Thyroid Eye Disease
Thyroid Eye Disease (TED)
Phase 32026-03-17
RecruitingA Study of MHB009C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Phase 1 / Phase 22026-03-17
RecruitingA Study of MHB048C in Patients With Advanced Solid Tumors
mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor
Phase 1 / Phase 22026-01-16
RecruitingOpen-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
Thyroid Eye Disease (TED)
Phase 32026-01-09
RecruitingA Study of MHB042C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Phase 1 / Phase 22025-11-27
RecruitingA Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant S
Advanced Breast Cancer, Advanced Malignant Solid Tumor
Phase 22025-09-30
RecruitingA Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumor
Phase 1 / Phase 22025-09-18
RecruitingMHB018A Treatment in Patients With Active Thyroid Eye Disease
Thyroid Associated Ophthalmopathies
Phase 32025-07-22
RecruitingA Study of MHB046C Injection in Patients With Advanced Solid Tumors
Advanced Solid Cancer
Phase 1 / Phase 22025-07-17
RecruitingA Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Advanced Lung Cancer
Phase 1 / Phase 22025-05-09
RecruitingA Study of MHB118C Injection in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Phase 12025-03-31
Active Not RecruitingA Study of MHB039A for Advanced Solid Tumor
Advanced Solid Tumor
Phase 1 / Phase 22024-04-16
Active Not RecruitingPhase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo
Vitiligo
Phase 22024-03-26
CompletedA Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 32023-06-10
Active Not RecruitingA Study of MHB036C for Advanced Solid Tumor
Advanced Solid Tumor
Phase 1 / Phase 22023-05-26
CompletedMH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 1 / Phase 22022-01-06